NCI-H810 - Cell Line (ID:50037)

Name: NCI-H810
Alternative Names: H810
Alternative ID: CLO_0008117
Parent Cell Line:
Reference Source: ATCC CRL-5816
Organism: Homo sapiens
Organ: lung
Cell Type: epithelial
Details of Cell Type:
Donor Sex: male
Donor Age:
Donor Ethnicity:
Donor Health Status:
Disease: DOID:3910, lung adenocarcinoma, DOID:4556, large cell carcinoma
Details of Disease: NSCLC giant cell carcinoma
Production Details:
Genetic Modification(s): none
Known Mutations:
Citation Information for Mutations: COSS925341
Verification Reference Profile: DNA Profile (STR, source: ATCC): Amelogenin: X,Y CSF1PO: 10 D13S317: 12,13 D16S539: 9 D5S818: 11 D7S820: 10 THO1: 7,9 TPOX: 10,11 vWA: 15,16
Growth Properties: adherent
Recommended Culture Conditions: From MGH/CMT as specified by cell provider: HITES medium supplemented with 5% fetal bovine serum. HITES medium with 5% fetal bovine serum is formulated at the ATCC as follows: Dulbecco's medium : Ham's F12, 50:50 mix (ATCC 30-2006) Insulin 0.005 mg/ml Transferrin 0.01 mg/ml Sodium selenite 30 nM Hydrocortisone 10 nM beta-estradiol 10 nM HEPES 10 mM L-glutamine 2 mM (in addition to that in the base medium) fetal bovine serum 5%
Relevant Citations:
Usage Note:
Date Publicly Available: 2012-04-25
Most Recent Update: 2016-04-04

Batch Information for HMSL50037-2:

HMS LINCS Batch ID: 50037-2
Provider: Center for Molecular Therapeutics (CMT; Massachusetts General Hospital)
Provider Catalog ID: MGH-804
Provider Batch ID:
Source Information: Obtained by Yangzhong Tang (Harvard Medical School) from the Center for Molecular Therapeutics (CMT; Massachusetts General Hospital) (contact: Cyril Benes).
Date Received:
HMS QC Outcome:
Transient Modification(s):
Date Publicly Available: 2016-06-06
Most Recent Update: 2016-07-12